Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Time to Sell?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s share price gapped down before the market opened on Monday . The stock had previously closed at $3.5050, but opened at $3.31. Curaleaf shares last traded at $3.55, with a volume of 56,641 shares trading hands.

Analyst Ratings Changes

Separately, Zacks Research upgraded Curaleaf from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. Three analysts have rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Strong Buy”.

Curaleaf Stock Performance

The business has a 50-day moving average of $2.97 and a two-hundred day moving average of $2.68. The company has a market cap of $2.50 billion, a P/E ratio of -27.54 and a beta of 1.53. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.56 and a quick ratio of 0.74.

Curaleaf’s stock is set to reverse split on the morning of Friday, June 5th. The 1-3 reverse split was announced on Tuesday, May 26th. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, June 4th.

Curaleaf (OTCMKTS:CURLF) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.09 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.17. The company had revenue of $324.23 million for the quarter, compared to the consensus estimate of $316.62 million. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%. On average, sell-side analysts predict that Curaleaf Holdings, Inc. will post -0.1 EPS for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.